{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:32:13Z","timestamp":1775327533058,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>Follicular lymphoma (FL) is one of the most common subtypes of non\u2010Hodgkin lymphoma and frequently transforms to diffuse large B\u2010cell lymphoma (DLBCL). To clarify some aspects of the natural history of FL, we retrospectively examined 43 consecutive patients who had DLBCL with pre\u2010 or coexisting FL grade 1 or 2. The patients comprised 22 men and 21 women with a median age of 53 years. Most of the patients (34\/43) showed advanced\u2010stage (III or IV) disease initially. We examined both FL and DLBCL components morphologically, immunohistochemically, and by interface fluorescence <jats:italic>in situ<\/jats:italic> hybridization (FISH: IGH\/BCL2 fusion, <jats:italic>BCL6 translocation<\/jats:italic>) analysis. Most of the DLBCLs were classified as the centroblastic subtype, with two exceptions of the anaplastic subtype. Immunohistochemical analysis of both the FL and DLBCL components revealed the following respective positivity rates: CD20\u00a0100%\/100%, CD10 86%\/66%, Bcl\u20102 96%\/91%, Bcl\u20106 84%\/88%, MUM1 16%\/34%, CD30 0%\/20%, CD138 0%\/0%, and CD5 0%\/3%. Loss of CD10 (<jats:italic>6\/36, 17%<\/jats:italic>) and gain of MUM1 (<jats:italic>7\/28, 25%<\/jats:italic>) and CD30 (<jats:italic>5\/21, 24%<\/jats:italic>) through transformation were not infrequent. High positivity rates for Bcl\u20102 and Bcl\u20106 were maintained throughout transformation. Among the DLBCLs, 84% were classified as the germinal center B\u2010cell phenotype (GCB) and 16% as non\u2010GCB in accordance with the criteria of Hans <jats:italic>et\u00a0al<\/jats:italic>. IGH\/BCL2 fusion was detected by FISH in 89% of FLs and 82% of DLBCLs. BCL6 translocation was detected in 1\/6 (17%) DLBCLs without IGH\/BCL2 fusion. Thus, although the morphological features and FISH results for DLBCL were consistent with transformed FL, the immunophenotype showed wide heterogeneity. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 1760\u20131768)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.00873.x","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T01:21:54Z","timestamp":1213233714000},"page":"1760-1768","source":"Crossref","is-referenced-by-count":40,"title":["Diffuse large B\u2010cell lymphoma after transformation from low\u2010grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses"],"prefix":"10.1111","volume":"99","author":[{"given":"Akiko Miyagi","family":"Maeshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuko","family":"Omatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung\u2010Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412063112303"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.10.1470"},{"key":"e_1_2_6_5_2","first-page":"823","volume-title":"Neoplastic Hematopathology","author":"Harris NL","year":"2001"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199705000-00004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.3.758.758"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805263182106"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904223401604"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3804"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.7.1994.1994"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.8.2289.2289"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.12.4677"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V84.4.1043.1043","article-title":"Prognostic value of chromosomal abnormalities in follicular lymphoma","volume":"84","author":"Tilly H","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06439.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402739"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4265"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00014.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02068.x"},{"key":"e_1_2_6_24_2","first-page":"171","volume":"162","author":"Jaffe ES","year":"2001","journal-title":"World Health Organization Classification of Tumors, Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.12.4708"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.144.9.3602","article-title":"Deregulated Bcl\u20102 gene expression selectively prolongs survival of growth factor\u2010deprived hemoopietic cell lines","volume":"144","author":"Nunez G","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_6_27_2","first-page":"864","article-title":"Frequency of bcl\u20102 expression in non\u2010Hodtkin lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B\u2010cell hyperplasia","volume":"11","author":"Lai R","year":"1998","journal-title":"Mod Pathol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/8.suppl_2.S101","article-title":"Bcl\u20106 protein expression in normal and neoplastic lymphoid tissues","volume":"8","author":"Falini B","year":"1997","journal-title":"Ann Oncol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01979.x"},{"key":"e_1_2_6_30_2","first-page":"860","volume-title":"Neoplastic Hematopathology","author":"Anagnostopoulos I","year":"2001"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(99)00262-0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880373"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2084"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401696"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00810.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.815"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1309\/8EX5B9JFHPEK82BU"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1286"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:58:43Z","timestamp":1697237923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.00873.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,21]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1349-7006.2008.00873.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00873.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,21]]}}}